MedTrace Logo

Comparison of the Effects of Bevacizumab Before vs After Pattern Panretinal Photocoagulation

NCT00804206 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2024-05-30

No results posted yet for this study

Summary

Compare the effect of an intravitreal injection of bevacizumab previous or posterior of panretinal laser photocoagulation (PRLP) with a pattern laser; to prevent and reduce diabetic macular edema (DME) in patients with proliferative diabetic retinopathy (PDR) with DME.

Conditions

  • Macular Edema

Interventions

DRUG

bevacizumab

Intravitreal bevacizumab before panretinal photocoagulation

DRUG

bevacizumab

Intravitreal Bevacizumab after panretinal photocoagulation

Sponsors & Collaborators

  • Asociación para Evitar la Ceguera en México

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2008-07-31
Completion
2008-07-31

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00804206 on ClinicalTrials.gov